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  A B S T R A C T
Rodent control is carried out extensively in New Zealand to protect the native 
fauna and flora. This review outlines the advantages and disadvantages of 
different rodenticides as alternatives to sodium fluoroacetate (1080), and their 
suitability for aerial application. It includes existing rodenticides and those in 
the registration ‘pipeline’, as well as those that are not currently available in 
New Zealand. In the short to medium term, the focus for aerial baits should 
be on those compounds already registered in New Zealand or other countries. 
Aerial brodifacoum baiting is appropriate in isolated situations, but is not suitable 
for repeated use on the mainland, as brodifacoum is highly persistent and will 
bioaccumulate. Diphacinone has been registered for field use in New Zealand 
and the US Environmental Protection Agency has recently registered it for aerial 
control of rodents for conservation purposes; therefore, this is a logical first 
choice for control in New Zealand. Cholecalciferol is the next best option, as 
there is no secondary poisoning and thus there would be lower risk to non-target 
bird species; this is currently registered for field use as a rodenticide in bait 
stations. The third option is cholecalciferol in combination with coumatetralyl, 
which should be more effective than cholecalciferol alone, and the fourth is 
zinc phosphide. In the longer term, the preferred alternative to 1080 would 
be a novel, humane red blood cell toxin, related to para-aminopropiophenone 
(PAPP). PAPP is an attractive new pesticide that is being developed for stoat 
(Mustela erminea) and feral cat (Felis catus) control; however, the rodenticidal 
potential of this class of compounds still remains to be determined. Availability 
and registration status could influence this priority list in the future. A strategy 
to manage mice (Mus musculus) and sustain rat (Rattus spp.) control needs to 
be flexible and integrate non-anticoagulant and anticoagulant use.
Keywords: rodents, rodenticides, aerial control, anticoagulants, non-
anticoagulants
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 1. Introduction
Three rodent species were introduced to New Zealand from Europe. The 
Norway rat (Rattus norvegicus) arrived in the late 1700s and, away from human 
habitation, is mainly associated with wetland habitats. The ship rat (Rattus 
rattus) arrived towards the end of the 19th century and is the most widespread 
species in New Zealand, particularly suited to forested areas. The house mouse 
(Mus musculus) is widely distributed throughout the country in forests, sand 
dunes, pastures and tussock grasslands. Both ship and Norway rats have a direct 
impact on native wildlife by eating birds, eggs, lizards and invertebrates. The ship 
rat is generally a greater threat because of its climbing ability. Mice are predators 
of native invertebrates and, on occasion, small reptiles and birds (Innes 2005). 
Sodium fluoroacetate (1080) is the vertebrate pesticide widely used for aerial 
control of possums (Trichosurus vulpecula) and rodents in New Zealand 
(Eason 2002). However, its use is controversial, and it remains under scrutiny 
by the Environmental Risk Management Authority (ERMA) and the broader 
community (Philp 2009). Although 1080 can be very effective at culling animal 
pests (a solution developed in the 1940s), its use faces increasing and often 
fiercely articulated environmental, welfare and social pressures. Ironically, the 
1080 debate has become more polarised since the ERMA reassessment in 2007 
(Philp 2009). Therefore, New Zealand needs new, publicly acceptable rodent and 
possum toxins that can be aerially applied. It would also be advantageous to use 
toxins that act on different physiological processes, to prevent the development 
of bait shyness, aversion and resistance (Eason et al. 2008). This review evaluates 
the merits of a range of rodenticides as alternatives to sodium fluoroacetate 
(1080), particularly with regard to their suitability for aerial application for 
rodent control.
Rodenticides are classified into two categories: non-anticoagulant acute poisons 
and anticoagulants (Table 1). The anticoagulants are themselves separated 
into first-generation and second-generation chemicals: the second-generation 
anticoagulants were developed later and are more toxic. A new candidate 
vertebrate pesticide, para-aminopropiophenone (PAPP), is also currently being 
developed for predator control, and this compound, analogues, or compounds 
with a similar mode of action may have potential as a safer rodenticide 
(Eason et al. 2008, 2009). 
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In the following sections, the history, mode of action and appropriateness of 
different rodenticides for aerial control of rodents are reviewed. The key features 
of the existing or former non-anticoagulant rodenticides are first covered, 
followed by the key features of the existing anticoagulant rodenticides. The 
potential of the new candidate vertebrate pesticide PAPP is then explored. An 
analysis of the relative merits of the compounds described and current research 
and development activities in this field are considered in the closing discussion 
sections. The review has been assisted by a new Lincoln University Foundation 
for Research, Science and Technology (FRST) programme entitled ‘Smart Pest 
Control’ (March 2007 to June 2009), which is focusing on new multispecies 
baits, including solid baits containing 1080, zinc phosphide and cholecalciferol, 
for ground and aerial control of rodents and possums. 
TABLE 1.    COMMON AND CANDIDATE RODENTICIDES AND vERTEBRATE PESTICIDES. 
Adapted from information in Hone & Mulligan (1982) and Prakash (1988).
* (1) = first-generation anticoagulant; (2) = second-generation anticoagulant. See section 4 for further explanation about indandiones and 
coumarins.
ExISTING AND OLDER  NOvEL ANTICOAGULANT  ANTICOAGULANTS* COMBINATIONS
NON-ANTICOAGULANTS COMPOUND INDANDIONES COUMARINS 
Zinc phosphide  Para-aminopropiophenone (PAPP) Pindone (1) Warfarin (1) Cholecalciferol +
Strychnine  Diphacinone (1) Coumatetralyl (1) coumatetralyl
Cholecalciferol   Brodifacoum (2) 
Bromethalin    
Norbormide 
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 2. Non-anticoagulant rodenticides
This section outlines the advantages and disadvantages of a range of non-
anticoagulant poisons. Each of these compounds has a different mode of action 
and different properties. 
 2 . 1  Z I N C  P H O S P H I D E
  General information and history of use
Zinc phosphide was first used as a rodenticide in 1911 in Italy (Marsh 1987; 
US EPA 1998). It is an effective acute field rodenticide and was the most widely 
used rodenticide worldwide until the introduction of anticoagulant compounds 
in the 1940s and 1950s (US EPA 1998). It is still used as a rodenticide in the USA, 
Europe, Australia, the Asia-Pacific region and China (Marsh 1987). In the USA and 
Australia, it is used for field control of rodents, having found favour because of 
the comparatively low risk of secondary poisoning following its field use when 
compared with strychnine or 1080 (Marsh 1987; Eason et al. 2008). 
Zinc phosphide has been developed in a paste bait in New Zealand, firstly as a 
back-up alternative to 1080 for possum control. An extensive database has been 
amassed to support the registration of a paste containing 1.5% zinc phosphide 
for possum control. This was filed with the New Zealand Food Safety Authority 
(NZFSA) in July–August 2008 and with ERMA in December 2008. The Animal Health 
Board (AHB) has funded the development of zinc phosphide for possum control, 
and its use in multispecies baits for controlling rats and mice is currently being 
developed as part of the Lincoln University FRST programme. As an extension to 
this programme, solid bait that would be suitable for aerial application will be 
developed, if this research continues beyond 2009.
  Mode of action
Zinc phosphide is a fast-acting compound, with clinical signs of poisoning first 
appearing from 15 minutes to 4 hours after intake and, following a lethal dose, 
death generally occurring in 3–12 hours (Marsh 1987). The oral toxicity of zinc 
phosphide is accounted for by the toxicity of the phosphine it produces when 
hydrolysed by stomach acid. The emetic action of the zinc portion reduces the 
toxicity of zinc phosphide to some non-target species; however, rats lack a 
vomiting reflex (Marsh 1987; US EPA 1998). Death is mediated by a combination 
of cardiac failure and respiratory failure (Osweiler et al. 1985). The poison is 
considered moderately humane (similar to 1080) (Fisher et al. 2004). 
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  Toxicity
Zinc phosphide is a broad-spectrum toxin, but there are some marked differences 
in susceptibility between species (Table 2). The LD50 for Norway rats is 
around 40 mg/kg. Some bird species are more susceptible to zinc phosphide 
(e.g. LD50 for the white-throated goose (Anser albifrons) is 7–5 mg/kg) (Hone & 
Mulligan 1982). 
SPECIES LD50 mg/kg
Pig (Sus scrofa) 20–40
Dog (Canis familiaris) 20–40
Cat (Felis catus) 40
Norway rat (Rattus norvegicus) 40
Kiore (Pacific rat) (Rattus exulans) 23
Goose (Anatidae) 7.5
Northern bobwhite (Colinus virginianus) 13
Duck (Anas platyrhyncha) 36
TABLE 2.    ACUTE ORAL TOxICITy (LD50 mg/kg)  FOR ZINC PHOSPHIDE.
Prepared from information contained within Hone & Mulligan (1982).
  Summary of key features
Advantages: Disadvantages:
•	 Highly	toxic	to	rodents	 •	 Lacks	specificity	and	more	toxic	to	
•	 Inexpensive	 	 birds	than	mammals
•	 Used	in	the	field	in	USA/Australia	 •	 No	antidote
•	 Non-persistent	 •	 Not	yet	registered	in	New	Zealand—	
•	 Comparatively	low	secondary		 	 pending	2009/10
 poisoning risk
  Recommendations
Zinc phosphide is not recommended for aerial control of rodents at this time 
because of the potential hazard to non-target species. Once registrations are 
achieved firstly for possum control and subsequently for multispecies baits 
targeting rodents and possums, aerial application of solid baits containing 
zinc phosphide could be progressed if field experience with ground baiting is 
favourable. However, special attention would need to be taken with regard to 
non-target impacts on birds.
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 2 . 2  S T R y C H N I N E
  General information and history of use
Strychnine is found in the seeds of the tree Strychnos nux-vomica. The alkaloid 
has been used for rodent and vertebrate pest control since the mid-1800s 
(Schwartze 1922). The first recorded use of strychnine in Australia was in the 
1880s, and it is still used there to control mouse plagues (Mutze 1989). In 1986, 
the US Environmental Protection Agency (EPA) suspended all above-ground 
registrations of strychnine, allowing only underground uses (US EPA 1996). It is 
not currently registered for use in New Zealand.
  Mode of action
Strychnine is a fast-acting poison that is readily absorbed into the circulatory 
system from the intestinal tract. Highest concentrations of strychnine are found 
in the blood, liver and kidneys. It is a neurotoxin. Poisoned animals often die 
in less than 1 hour as a result of respiratory failure (asphyxia), but death may 
take 24 hours or longer. Strychnine is considered inhumane, with the typical 
signs of strychnine poisoning being restlessness and muscular twitching, which 
progress to convulsive seizures and violent muscular spasms before death 
(Osweiler et al. 1985). 
  Toxicity
The LD50 for Norway rats is 5–6 mg/kg (Prakash 1988). The oral LD90 for mice is 
approximately 5 mg/kg. It is highly toxic to all mammals, but slightly less so to 
birds (Mutze 1989) (Table 3). 
TABLE 3.    ACUTE ORAL TOxICITy (LD50 mg/kg)  OF STRyCHNINE.
Prepared from information provided in Hone & Mulligan (1982) and Osweiler et al. (1985).
SPECIES LD50 mg/kg
Rat (Rattus rattus) 5–6
Mouse (Mus musculus) 5
Cat (Felis catus) 0.75
Norway rat (Rattus norvegicus) 6.8
Duck (Anas platyrhyncha) 2.9
Pigeon (Columba livia) 2.1
  Summary of key features
Advantages: Disadvantages:
•	 Highly	toxic	to	rodents	 •	 Causes	secondary	poisoning	
•	 Inexpensive	 •	 Inhumane
	 	 •	 Not	registered	for	use	in	New	Zealand
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  Recommendations
Strychnine is not recommended for aerial control of rodents. It is inhumane, 
hazardous, would cause secondary poisoning and is not registered in 
New Zealand.
 2 . 3  C H O L E C A L C I F E R O L
  General information and history of use
Cholecalciferol (vitamin D3) was developed as a rodenticide in the 1980s (Marshall 
1984). It was first registered in New Zealand in 1999, in paste bait containing 
0.8% cholecalciferol (Feracol®). This was based on work carried out in the early 
1990s, which demonstrated the susceptibility of possums to cholecalciferol 
(Eason 1991; Eason et al. 1996). It is registered as an alternative to 1080 for 
possum control because of the relative low risk of secondary poisoning of dogs 
(Canis familiaris) and low toxicity to birds (Eason et al. 2000). In 2008, the 
registration status of the bait Feracol® containing 0.8% cholecalciferol was 
extended to cover rodents as well as possums, based on data from pen and field 
efficacy trials (Baigent et al. 2007; Hix et al. 2007) and currently, in 2009, a paste 
and solid bait formulation containing 0.4% cholecalciferol is being developed 
(Hix et al. 2009).
  Mode of action
Death usually occurs 3–7 days after a lethal dose (Marshall 1984; Eason et al. 
1994). To become biologically and toxicologically active, cholecalciferol 
must undergo metabolic conversion to 25-hydroxycholecalciferol (25OHD). 
This metabolite is then transferred to the kidney and converted to 24-, 25- or 
1,25-dihydroxycholecaliferol. The latter metabolite is the most biologically 
active form of vitamin D3 (Keiver et al. 1988). At toxic doses, this active 
metabolite mobilises calcium stores from the bones into the bloodstream, while 
also decreasing calcium excretion by the kidneys. The net result is calcification 
in the cardiovascular system, kidneys, stomach, lungs and muscles. In possums 
and rodents, death probably occurs as a result of heart failure. In other species, 
including cats (Felis catus) and dogs, renal failure (caused by vessel blockage 
and	nephrocalcinosis—calcium	deposition	 in	 the	kidneys)	 and	gastrointestinal	
haemorrhage appear to be more prominent (Dorman & Beasley 1989; 
Jolly et al. 1993).
Sub-lethal poisoning of target species can cause prolonged anorexia and wasting, 
which creates ethical and animal welfare concerns. Therefore, current baits 
are designed with the appropriate concentration of cholecalciferol to ensure 
maximum potency and limited suffering (Eason et al. 1996). Cholecalciferol is 
likely to cause some discomfort prior to death, but is considered more humane 
than anticoagulants (O’Connor et al. 2003a). 
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  Toxicity
There is variation between species in the response to cholecalciferol, and 
importantly birds are less susceptible than mammals (Eason et al. 2000). The 
LD50 for cholecalciferol in Norway rats and house mice is very similar. Possums 
and rabbits (Oryctolagus cuniculus) appear to be particularly sensitive to 
cholecalciferol (Jolly et al. 1995). In the USA, the use of cholecalciferol has 
also been explored for controlling rock squirrels (Spermophilus spp.), gophers 
(Thomomys spp.) and ground squirrels (Spermophilus spp.) (Tobin et al. 1993). 
Cats appear to be less susceptible than possums, but toxicity is less consistent, 
with some cats surviving doses of up to 200 mg/kg, and others dying at 
50 mg/kg. The LD50 in ducks (Anas platyrhyncha) is > 2000 mg/kg (Eason et al. 
2000) (Table 4).
Cholecalciferol baits prove fatal to rats and mice if eaten in sufficient amounts 
over 1 night. A lethal dose may also accumulate after 2 or 3 nights of feeding. 
As a general rule, field results are best if sufficient bait is eaten on the first and 
second nights. Cholecalciferol is considered especially useful for controlling 
house mice, because mice have sometimes proven more difficult to control with 
anticoagulant rodenticides.
SPECIES LD50 mg/kg
Rabbit (Oryctolagus cuniculus) 9.0
Possum (Trichosurus vulpecula) 16.8* 
Norway rat (Rattus norvegicus) 42.5
Mouse (Mus musculus) 43.6
Dog (Canis familiaris) 80.0
Duck (Anas platyrhyncha) 2000.0
TABLE 4.    ACUTE ORAL TOxICITy (LD50 mg/kg)  OF CHOLECALCIFEROL. 
Prepared from information provided in Eason (1993), Eason et al. (1994) and  
Jolly et al. (1995).
* Reduced to 9.8 mg/kg when administered with calcium.
  Summary of key features
Advantages: Disadvantages:
•	 Effective	rodenticide	 •	 Expensive	compared	to	1080	
•	 Low	risk	of	secondary	poisoning	 •	 Although	treatment	for	accidental
•	 Less	toxic	to	birds	than	1080	 	 poisoning	of	pets	is	available,	this	is
•	 A	useful	single-dose	alternative	to		 	 complex
 1080
•	 No	long-term	residue	risks	in		
 sub-lethally exposed animals 
•	 Currently	registered	for	use	in	
 New Zealand
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  Recommendations
Cholecalciferol is worth considering as a toxin for aerial control of rodents. 
However, lethal and sub-lethal poisoning of non-target species, e.g. pigs 
(Sus scrofa) and deer (Cervidae), would need to be avoided, as this could cause 
prolonged sickness and loss of appetite. In aerial bait, cholecalciferol would 
have lower risk to non-target bird species than zinc phosphide or 1080. The new 
low-dose cholecalciferol at 0.4% would have less risk to non-targets and is likely 
to be less expensive than the current 0.8% formulation.
 2 . 4  B R O M E T H A L I N
  General information and history of use
Bromethalin was developed in the 1970s. It is a single-feeding rodenticide that 
is registered for use in the USA; however, its use is restricted to bait stations in 
and around buildings for the control of commensal rodents (Dreikorn 1978). In 
the 1970s, bromethalin was evaluated for use in Europe; however, because of 
concerns regarding humaneness, the dossier was not submitted and bromethalin is 
not registered in Europe (Alan Buckle, formally with Zeneca, UK, pers. comm.).
  Mode of action
Bromethalin-poisoned animals do not feel ill immediately, allowing for adequate 
ingestion of the toxin. Appetite is suppressed after ingestion of a lethal dose 
and death does not occur until 2 days after ingestion. Poisoned animals exhibit 
tremors, convulsions and prostration prior to death, which usually occurs within 
18 hours of the onset of symptoms. Bromethalin is a neurotoxicant and rodents 
that are resistant to anticoagulants show no resistance to bromethalin. Possums 
are not susceptible to poisoning with bromethalin, so it could only be used to 
target rodents.
Bromethalin uncouples oxidative phosphorylation in the mitochondria of the 
central nervous system. This leads to diminished activity of the enzyme that 
transports sodium and potassium across the cell membrane (Na+/K+ ATPase), 
which results in a fluid build-up manifested as fluid-filled vacuoles between 
the myelin sheaths (the cover surrounding nerve cells) (Dreikorn 1978). This 
vacuole formation in turn leads to an increased cerebrospinal fluid pressure 
and increased pressure on nerve axons, resulting in reduced nerve impulse 
conduction, paralysis and death. 
  Toxicity
Bromethalin is toxic to most species at ranges of 2–13 mg/kg (Table 5). In the 
USA, non-target impacts are limited by the restriction of the use of this poison 
to small-scale rodent infestations. Secondary poisoning studies in dogs have 
demonstrated that they are at low risk (Jackson et al. 1982). However, based on 
poisoning incidents, it seems that cats are more susceptible than dogs.
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  Summary of key features
Advantages: Disadvantages:
•	 Highly	toxic	to	rodents	 •	 Lacks	specificity—toxicity	to	birds	
•	 Alternative	to	1080	 	 and	mammals	similar
•	 Comparatively	low	secondary		 •	 No	antidote
	 poisoning	risk	 •	 Not	registered	for	use	in	New	Zealand
  Recommendations
The development of bromethalin for aerial control of rodents is not recommended 
at this time. It has no special advantages over other alternatives to 1080 and, 
unlike cholecalciferol, is toxic to birds and is not currently registered in 
New Zealand.
 2 . 5  N O R B O R M I D E
  General information and history of use
Norbormide is a selective rat toxicant, being specifically toxic to Norway 
rats. It was developed in the 1960s, but its use was discontinued in the 
1970s as anticoagulant toxins became more popular. Taste aversion limited 
its effectiveness and field efficacy results were poor (Telle 1967). Landcare 
Research has been investigating ways of overcoming taste aversion to norbormide 
and the development of analogues (Bova et al. 2001; Cavalli et al. 2004; 
Ricchelli et al. 2005). 
  Mode of action
After a lethal dose, very minor symptoms can occur within the first few minutes; 
more pronounced symptoms occur after 30 minutes and most deaths occur 
within 8–24 hours. Norbormide causes vasoconstriction (narrowing) of small 
arteries and vasodilation (widening) of large arteries in rats (Roszkowski et al. 
1964; Roszkowski 1965; Bova et al. 1996), which causes a rapid fall in blood 
pressure. Death probably results from circulatory disorders and heart failure due 
to irreversible coronary constriction. The constriction of small blood vessels is 
rapid and unique to rats (Bova et al. 1996, 2001; Cavalli et al. 2004; Ricchelli et 
al. 2005). As it is comparatively fast acting, it is likely to be more humane than 
most other rodenticides.
TABLE 5.    ACUTE ORAL TOxICITy (LD50 mg/kg)  FOR BROMETHALIN.
Prepared from information in Hone & Mulligan (1982). 
SPECIES LD50 mg/kg
Rat (Rattus rattus) 2.0–10
Cat (Felis catus) 1.8
Rabbit (Oryctolagus cuniculus) 13
Chicken (Gallus domesticus) 8.3
Northern bobwhite (Colinus virginianus) 4.6 and 11.0
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  Toxicity
Norbormide is toxic to Norway rats. Ship rats are less susceptible, and mice and 
all other species are resistant to this toxin (Table 6). The lack of toxicity of this 
compound to most animals makes it unique.
SPECIES ROUTE OF  LD50 mg/kg (RANGE) 
 ADMINISTRATION 
Brown rat (wild Norway rat) (Rattus norvegicus) Oral 12 (10–13)
Black rat (ship rat) (Rattus rattus) Oral 52.0 (47.0–57.0)
Wild Hawaiian rat (Rattus exulans) Oral c. 10
Cotton rat (Sigmodon hispidus) Oral 300–1000
Mouse (Mus musculus) Intraperitoneal 390 (291–523)
 Oral 2250 (1760–2880)
White-footed deer mouse (Peromyscus leucopus) Oral > 1000
Cat (Felis catus) Oral > 1000
Dog (Canis familiaris) Oral  > 1000
Rabbit (Oryctolagus cuniculus) Oral > 1000
Duck (Anas platyrhyncha) Oral > 1000
Goose (Anatidae) Oral > 1000
Chicken (Gallus domesticus) Oral > 1000
Pigeon (Columba livia) Oral > 1000
Turkey (Melleagris gallopavo) Oral > 1000
TABLE 6.    ACUTE TOxICITy (MEAN LD50 mg/kg)  OF NORBORMIDE IN RATS, 
MAMMALS AND BIRDS. 
Prepared from information in Roszkowski et al. (1964), Roszkowski (1965) and Russell (1965).
  Summary of key features
Advantages: Disadvantages:
•	 Potentially	an	effective	rodenticide	 •	 Not	toxic	to	mice
•	 Low	risk	of	secondary	poisoning	 •	 Not	registered	in	any	country
•	 Less	toxic	to	birds	than	1080	 •	 Not	produced	in	commercial	
•	 A	useful	single-dose	alternative	to		 	 quantities	and	expensive
 1080
•	 No	long-term	residue	risks	in	
 sub-lethally exposed animals 
  Recommendations
The development of norbormide for aerial control of rodents in New Zealand 
is not recommended due to its lack of toxicity to mice and lower toxicity to 
most other rodents: whilst it is toxic to Norway rats, it is far less toxic to ship 
rats, which are the rodent of most concern in New Zealand. It is not currently 
registered in any other country and the lack of registrations dossiers for this 
compound would considerably delay it use.
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 3. Anticoagulant rodenticides
Anticoagulant rodenticides can be separated into two groups: first-generation 
anticoagulant rodenticides, which were developed between the 1940s and 
1960s, and second-generation anticoagulant rodenticides, which were developed 
in the 1970s and 1980s. All anticoagulant rodenticides have the same mode of 
action: they interfere with the normal synthesis of vitamin K-dependent clotting 
factors, which results in bleeding and death. However, the second-generation 
anticoagulants, which were developed partly to overcome resistance, are more 
toxic than the first-generation anticoagulants (Hadler & Shadbolt 1975). 
In the liver cells, the biologically inactive vitamin K1-2,3 epoxide is reduced by a 
microsomal enzyme into biologically active vitamin K, which is essential for the 
synthesis of prothrombin and other clotting factors (vII, Ix and x). Anticoagulant 
rodenticides’ antagonism of the enzyme vitamin K1-epoxide reductase causes 
a gradual depletion of the active form of the vitamin, and consequently of 
vitamin K-dependent clotting factors, which results in an increase in blood-
clotting time until the point where no clotting occurs. The greater potency of 
second-generation anticoagulants and their greater potential to affect wildlife 
is related to their greater affinity for the enzyme that reduces vitamin K 
(vitamin K-epoxide reductase), resulting in a greater accumulation and 
persistence of vitamin K in the liver and kidneys after absorption (Parmar et al. 
1987; Huckle et al. 1988). This in turn results in bioaccumulation through the 
food web, increasing non-target deaths after repeated field use for rodent control 
(Eason et al. 2002). There are two classes of anticoagulants: the indandiones 
and coumarins. The indandiones are less persistent in the liver of sub-lethally 
poisoned animals (Fisher et al. 2003), and therefore less likely to bioaccumulate 
in the food web. The first-generation anticoagulants contain representatives from 
each class, whereas all second-generation anticoagulants are coumarins. 
For all anticoagulants, death is likely to occur within 5–7 days of the initial ingestion 
of a lethal dose (Buckle & Smith 1994; Littin et al. 2000). All anticoagulants are 
considered relatively inhumane (O’Connor et al. 2003a), but are more acceptable 
in rodents (Littin et al. 2000) than in possums (Littin et al. 2002), as time to death 
is shorter (Litten et al. 2000).
The principal use of anticoagulants worldwide has been for the control of 
commensal rodents, primarily Norway rats, ship rats and house mice. For 
example, brodifacoum, a second-generation anticoagulant, is aerially sown 
for rodent control on islands in New Zealand and around the world, and has 
been very successful (Eason et al. 2001). However, any field use of persistent 
anticoagulants has been controversial, and in the USA concerns about wildlife 
contamination have resulted in the EPA Rodenticide Mitigation Decision 
May 28th 2008, which stated that all second-generation anticoagulant rodenticides 
(SGARs) such as brodifacoum were to be removed from the consumer market 
and could only be sold for use by farmers and only around farm buildings; an 
exception to this is for ‘one-off’ conservation use, e.g. for islands. Only two 
rodenticides, brodifacoum and diphacinone, have been registered in the USA for 
aerial control of rodents (US EPA 2008). 
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In the sections below, several first-generation anticoagulants are reviewed. 
However, only one second-generation anticoagulant is discussed (brodifacoum). 
This is because it has already been established that brodifacoum is effective 
for aerial control of rodents, albeit with side effects that make it unsuitable for 
repeated use, and that the other second-generation anticoagulants have similar 
toxicological properties with no advantages over brodifacoum (Eason et al. 2001, 
2002). Brodifacoum, like other second-generation anticoagulants, is not readily 
metabolised and the major route of excretion of unbound compound is through 
the faeces. This means that there is a far greater risk of secondary poisoning to 
non-target species than for the first-generation anticoagulants. Where there is 
repeated field use, widespread wildlife contamination extends to native birds 
as well as game species (young & de Lai 1997; Eason et al. 2002). Hence, the 
important question to be addressed is which of the first-generation anticoagulant 
rodenticides is most appropriate as an alternative to brodifacoum when repeat 
rodent control is needed. 
 3 . 1  F I R S T - G E N E R A T I O N  A N T I C O A G U L A N T S
 3.1.1 Pindone 
  General information and history of use
Pindone belongs to the indandione class of anticoagulants. Pindone was 
synthesised in 1937 (Beauregard et al. 1955) and was developed as a pesticide in 
the early 1940s. It has been used worldwide to control rodents, though its use 
for the control of rats and mice has decreased following the introduction of more 
potent anticoagulants, such as diphacinone. Pindone has proved most effective 
for rabbit control (Eason & Jolly 1993). To control rodents, it is used in baits 
containing 250 mg/kg (250 ppm) active ingredient (Prakash 1988).
  Mode of action
Like the other anticoagulant toxicants, pindone interferes with the normal 
synthesis of vitamin K-dependent clotting factors in the liver. Clinical signs 
of toxicosis in animals will usually reflect some manifestation of haemorrhage 
(Osweiler et al. 1985), which causes pain or discomfort depending on the site of 
the haemorrhage in the body (Littin et al. 2000, 2002). 
  Toxicity
There are limited acute toxicity data available for pindone, but these data show 
variation between species (Table 7). For first-generation anticoagulants such as 
pindone, either very large single doses or repeated smaller doses are generally 
needed to induce death. However, rabbits appear to be particularly susceptible 
to pindone: a single dose of approximately 18 mg/kg is sufficient to kill rabbits, 
and the repeat dose (7 days) LD50 is only 0.52 mg kg
–1 day–1. In contrast, pindone 
doses of up to 12 mg kg–1 day–1 do not cause clinical or post-mortem haemorrhage 
in sheep (Ovis aries), and possums appear to be even more resistant to pindone, 
with an LD50 of 51 mg kg
–1 day–1 for 5 days (Jolly et al. 1994).
Non-target research conducted in Australia provides information on the 
susceptibility of horses (Equus caballus), cattle (Bos taurus), goats (Capra 
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  Summary of key features
Advantages: Disadvantages:
•	 Effective	for	rodent	control	 •	 Not	potent	
•	 Highly	effective	for	rabbit	control	 •	 Inhumane	in	larger	animals
•	 Antidote	available	
•	 Less	persistent	than	brodifacoum	
•	 Registered	for	use	in	New	Zealand
  Recommendations
Pindone is a possible option for aerial control of rodents and it is already registered 
in New Zealand. However, diphacinone (section 3.1.3) would be more effective, 
as it is more potent as a rodenticide (Buckle & Smith 1994). 
 3.1.2 Warfarin 
  General information and history of use
Warfarin belongs to the coumarin class of anticoagulants. Like pindone, it is one 
of the earliest first-generation anticoagulant rodenticides. It has been used in a 
range of rodent baits since it was first introduced in 1947 (Prakash 1988). 
  Mode of action
Like the other anticoagulants, warfarin inhibits the synthesis of vitamin K- 
dependent clotting factors. In addition, warfarin is reported to induce capillary 
damage. In general, the symptoms of poisoning appear relatively slowly. 
In rats, death is likely to occur within 5–7 days of the initial ingestion of a 
lethal dose, which is similar to other anticoagulants (Buckle & Smith 1994; 
Littin et al. 2000).
TABLE 7.    ACUTE ORAL TOxICITy (LD50 mg/kg)  OF PINDONE. 
Prepared from information in Beauregard et al. (1955), Oliver & Wheeler (1978),  
Hone & Mulligan (1982) and Eason & Jolly (1993).
SPECIES LD50 mg/kg
Rabbit (Oryctolagus cuniculus) 6–18
Dog (Canis familiaris) 50
Norway rat (Rattus norvegicus) 75–100
Sheep (Ovis aries) c. 100
Possum (Trichosurus vulpecula) > 100
hircus), chickens (Gallus domesticus), dogs and cats to pindone. All these 
species were less susceptible than rabbits (Martin et al. 1991). Pindone is rapidly 
eliminated following sub-lethal exposure (Fisher et al. 2003).
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SPECIES SINGLE DOSE (mg/kg) REPEATED DOSE (mg/kg)
Pig (Sus scrofa) 3 0.5
Dog (Canis familiaris) 50 5
Rat (unspecified) 50–100 1
Cat (Felis catus) 50–100 1
TABLE 8.    ACUTE ORAL TOxICITy (LD50 mg/kg)  OF WARFARIN. 
Prepared from information in Osweiler et al. (1985).
  Summary of key features
Advantages: Disadvantages:
•	 Effective	for	rodent	control	 •	 Not	potent	
•	 Antidote	available	 •	 Inhumane
•	 Less	persistent	than	brodifacoum	 •	 Not	registered	for	use	in	New	Zealand
  Recommendations
Warfarin is not recommended for aerial control of rodents, as it is not currently 
registered for use in New Zealand and has no advantages over diphacinone 
(see section 3.1.3). 
 3.1.3 Diphacinone
  General information and history of use
Diphacinone belongs to the indandione class of anticoagulants. It is more toxic 
than warfarin or pindone to most rodents. In New Zealand, it is registered 
primarily for rodent control, although it has also been incorporated into fish-
based bait for ferret (Mustela putorius) control. It has been identified as a 
non-persistent anticoagulant (Fisher et al. 2003). As mentioned above, diphacinone 
has been developed for field use in the USA and has recently been registered by 
the US EPA for aerial control of rodents for conservation purposes, providing an 
alternative to brodifacoum (US EPA 2008).
  Mode of action
Like other anticoagulants, diphacinone inhibits the formation of vitamin K- 
dependent clotting factors. Clinical and post-mortem signs of toxicosis and 
humaneness are as for other anticoagulants (Osweiler et al. 1985; Buckle & Smith 
1994; Littin et al. 2000).
  Toxicity
The toxicity of warfarin varies according to species and whether the individual 
was exposed to a single dose or multiple doses (Table 8). For example, in rats 
the single dose LD50 is 50–100 mg/kg, whereas the multiple dose LD50 is 1 mg/kg 
for 5 days (Osweiler et al. 1985).
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  Toxicity
There is some variation between species in susceptibility to the toxic effects of 
diphacinone (Table 9). Diphacinone is more toxic than pindone or warfarin to 
most rats and mice. A diphacinone dose of 3 mg/kg will kill rodents in 5–8 days. 
Rats can withstand relatively high single doses of this toxicant, but are unable 
to survive doses of < 1 mg/kg when ingested over 5 successive days (Hone & 
Mulligan 1982). The acute toxicity of diphacinone in mice has not been properly 
defined; however, mice on Buck Island have been killed after consuming an 
average dose of 46.9 mg/kg of diphacinone (Gary Witmer, National Wildlife 
Research Centre, USA, pers. comm.). This is much lower than the published LD50 
range of 141–340 mg/kg for mice (Hone & Mulligan 1982). The LD50 for 5 days 
also suggests that house mice are susceptible to diphacinone. 
As for pindone, diphacinone is rapidly eliminated from the liver (Fisher et al. 
2003). Consequently, diphacinone will have a lower tendency to cause secondary 
poisoning when compared with brodifacoum or similar second-generation 
anticoagulants.
SPECIES  LD50 mg/kg
Rat (unspecified) 3.0; < 1 over 5 days
Dog (Canis familiaris) 3.0–7.5
Cat (Felis catus) 14.7
Rabbit (Oryctolagus cuniculus) 35.0
Pig (Sus scrofa) 150.0
Mouse (Mus musculus) 7.05 over 5 days
Mallard duck (Anas platyrhynchos) 3158.0
TABLE 9.    ACUTE ORAL TOxICITy (LD50 mg/kg)  OF DIPHACINONE. 
Prepared from information in Hone & Mulligan (1982).
  Summary of key features
Advantages: Disadvantages:
•	 No	license	required	 •	 Less	potent	than	brodifacoum
•	 Effective	for	rodent	control	
•	 Antidote	available	
•	 Less	persistent	than	brodifacoum	
•	 Registered	for	use	in	New	Zealand	
•	 Approved	by	US	EPA	for	aerial		
 control of rodents 
  Recommendations
Diphacinone represents a safer alternative to brodifacoum for the repeat aerial 
control of rodents, and it is already being used in this manner for the eradication 
of rodents from islands (US EPA 2008). Diphacinone is reported to have 
similar potency to coumatetralyl, but is less persistent (Buckle & Smith 1994; 
Fisher et al. 2003), making it a preferred option. Its international registration 
status provides a platform of data and dossiers, which could be extended to 
support its use for aerial control of rodents in New Zealand.
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 3.1.4 Coumatetralyl 
  General information and history of use
Coumatetralyl belongs to the coumarin class of anticoagulants. It was developed 
in 1957, and is marketed worldwide as Racumin®. It is used as a tracking powder, 
or as a cereal bait, wax block or paste for rodent control. It is registered in 
New Zealand for rodent control (Eason & Wickstrom 2001).
  Mode of action
Like other anticoagulant rodenticides, coumatetralyl inhibits the formation 
of vitamin K-dependent clotting factors and rodents die within 5–7 days 
after ingesting a lethal dose of the toxin. Coumatetralyl is less persistent 
(in sub-lethally poisoned animals) than brodifacoum, but considerably more 
persistent than diphacinone (Parmar et al. 1987; Fisher et al. 2003), and will have 
similar humaneness to other anticoagulant rodenticides.
  Toxicity
There are comparatively few acute toxicity data for coumatetralyl (Table 10).
Aside from reports of pets gaining access to bait, there are also few references to 
non-target deaths. In recent studies, coumatetralyl-poisoned rat carcasses were 
fed to weka (Gallirallus australis) and ferrets: 1 out of 10 ferrets died, but no 
weka were killed (O’Connor et al. 2003b).
SPECIES LD50 mg/kg
Rat (Rattus rattus) 16.5 (single dose)
 0.3 (5 days)
Pig (Sus scrofa)  1.0–2.0 (1–7 days) 
Hen (Gallus domesticus) 50.0 (8 days)
TABLE 10.    ACUTE ORAL TOxICITy (LD50 mg/kg)  OF COUMATETRALyL. 
Prepared from information in Hone & Mulligan (1982).
  Summary of key features
Advantages: Disadvantages:
•	 Effective	for	rodent	control	 •	 Not	as	potent	as	brodifacoum	
•	 Antidote	available	 •	 More	persistent	than	diphacinone
•	 Less	persistent	than	brodifacoum	
•	 Registered	for	use	in	New	Zealand
  Recommendations
Coumatetralyl is already registered in New Zealand and has the potential to be 
used for aerial control of rodents, as a safer alternative to brodifacoum. However, 
diphacinone would be a better option, as it is reported to have similar potency 
to coumatetralyl but is less persistent. 
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 3.1.5 Cholecalciferol + coumatetralyl (C+C)
  General information and history of use
In Europe, cholecalciferol has been added to baits containing coumatetralyl 
(Racumin® plus) to overcome anticoagulant resistance in rats and mice 
(Pospischil & Schnorbach 1994). AHB has funded the development of 
cholecalciferol + coumatetralyl (C+C) for controlling possums, and it is currently 
being developed in multispecies baits for controlling rats and mice as part of 
the Lincoln University FRST programme (Eason et al. 2008). Bait containing 
0.015% cholecalciferol and 0.03% coumatetralyl has been developed, and dossiers 
are being prepared for submission for registration in 2009/10. C+C is effective 
at killing possums and rodents, even though the amount of cholecalciferol is a 
fraction of that used in current cholecalciferol baits (Pospischil & Schnorbach 
1994; Ray Henderson, Pest Tech Ltd, NZ, pers. comm.).
  Mode of action
Death occurs in 12 days in possums and 5 days in rats and mice (Ray Henderson, 
Pest Tech Ltd, NZ, pers. comm.). The primary toxic effects of C+C result 
from hypercalcaemia (i.e. cholecalciferol poisoning). Coumatetralyl acts as a 
synergist, enhancing cholecalciferol toxicity by blocking vitamin K2-dependent 
proteins that are involved in calcium regulation. These factors substantially 
enhance cholecalciferol-induced arterial and tissue mineralisation (Pospischil & 
Schnorbach 1994; Ray Henderson, Pest Tech Ltd, NZ, pers. comm.). C+C has a 
similar effectiveness to brodifacoum, but is less persistent and more humane, 
since animals poisoned with C+C will die more quickly than those poisoned with 
brodifacoum (Ray Henderson, Pest Tech Ltd, NZ, pers. comm.).
  Toxicity
At this stage, there is limited available data on this combination. Information 
is being generated in confidence to support a new product registration 
(Ray Henderson, Pest Tech Ltd, NZ, pers. comm.). Ruminants and birds are less 
susceptible to C+C than small mammalian pests (Table 11). 
* Death occurred over a 10-day period after eating 1–4 possums.
TABLE 11.    SUSCEPTIBILITy OF vARIOUS SPECIES TO CHOLECALCIFEROL + 
COUMATETRALyL (C+C). 
Data supplied by Ray Henderson (Pest Tech Ltd, NZ, pers. comm.).
SPECIES SUSCEPTIBILITy (% KILLED)
 PRIMARy POISONING  SECONDARy POISONING  
 (BAIT) (EATING POISONED POSSUMS)
Mouse (Mus musculus) 100% (n = 20)  
Rat (Rattus rattus) 100% (n = 20)  
Chicken (Gallus domesticus) 0% (n = 12)  0% (n = 12)
Sheep (Ovis aries) 0% (n = 12)  
Cat (Felis catus)  0.17% (n = 12)* 
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  Summary of key features
Advantages: Disadvantages:
•	 Effective	rodenticide	 •	 Not	yet	registered	for	use	in	
•	 Low	risk	of	secondary	poisoning	 	 New	Zealand—pending	2009/10
•	 Less	toxic	to	birds	than	1080	 •	 Although	treatment	for	accidental	
•	 A	useful	single-dose	alternative	to		 	 poisoning	of	pets	is	available,	this	is
 1080  complex
•	 No	long-term	residue	risks	in		
 sub-lethally exposed animals
  Recommendations
C+C is worth considering as a toxin for aerial control of rodents, since it will 
be as potent as brodifacoum (see below) without the concerns of prolonged 
contamination of the food web that dog the use of brodifacoum (Eason et al. 2002). 
Registration dossiers are being prepared initially for C+C for possum control, 
which could be extended to rodents and aerial control of rodents. It would have 
a lower risk to non-target bird species than zinc phosphide or 1080. 
 3 . 2  S E C O N D - G E N E R A T I O N  A N T I C O A G U L A N T S
 3.2.1 Brodifacoum 
  General information and history of use
Brodifacoum is the most well known and commonly used rodenticide worldwide. 
The rodenticidal properties of brodifacoum were first described in the early 
1970s (Hadler & Shadbolt 1975). It is a very potent anticoagulant that is active 
against rats and mice, including strains that are resistant to warfarin and 
other anticoagulants. A single ingestion of 1 mg/kg is usually sufficient to kill 
(Hone & Mulligan 1982). Brodifacoum has been used successfully in recent 
rodent eradication programmes on offshore islands (Eason et al. 2001) to protect 
populations of endangered indigenous birds. It is also used to control possums in 
New Zealand (Eason et al. 2002). 
  Mode of action
The onset of symptoms and death usually occur within 1 week in rodents (Littin 
et al. 2000). Like other anticoagulant toxicants, brodifacoum acts by interfering 
with the normal synthesis of vitamin K-dependent clotting factors in the liver. The 
resultant haemorrhaging will cause pain or discomfort and lameness, depending 
on the site of the haemorrhage in the body (Littin et al. 2000, 2002). 
24 Eason & Ogilvie—Potential rodenticides for aerial control of rodents
  Toxicity
As for all second-generation anticoagulants, only a single dose of brodifacoum is 
needed to induce death if sufficient toxicant is ingested. Brodifacoum is extremely 
toxic in a number of animal species, but the toxicity does vary between species 
(Table 12). In most mammals, LD50 values are 1 mg/kg or less. Some higher values 
have been reported in sheep and dogs, but there is considerable variability in 
these reports (LD50 in sheep = 5–25 mg/kg; and in dogs = 0.25–3.56 mg/kg).
SPECIES LD50 mg/kg
Pig (Sus scrofa) 0.1
Possum (Trichosurus vulpecula) 0.17
Rabbit (Oryctolagus cuniculus) 0.2
Cat (Felis catus) 0.25–25
Dog (Canis familiaris) 0.25–3.56
Rat (Rattus rattus) 0.27
Mouse (Mus musculus) 0.4
Bennett’s wallaby (Wallabia rufogrisea frutica) 1.3
Sheep (Ovis aries) 5–25
Canada goose (Branta canadensis) < 0.75
Pukeko (Porphyrio porphyrio melanotus) 0.95
Blackbird (Turdus merula) > 3.0
Hedge sparrow (Prunella modularis) > 3.0
Mallard duck (Anas platyrhynchos) 4.6
Black-billed gull (Larus bulleri) < 5.0
Silvereye (Zosterops lateralis) > 6.0
Australasian harrier (Circus approximans) 10.0
TABLE 12.    ACUTE ORAL TOxICITy (LD50 mg/kg)  OF BRODIFACOUM 
FOR MAMMAL SPECIES. 
Prepared from information in Godfrey (1985) and Eason & Spurr (1995).
  Summary of key features
Advantages: Disadvantages:
•	 Generally	available	 •	 High	risk	of	secondary	poisoning	
•	 Effective	for	rodent	control	 •	 Persistent	(>	9	months)	in	liver
•	 Antidote	available	 •	 Expensive	compared	to	1080
•	 Registered	for	use	in	New	Zealand
  Recommendations
Brodifacoum has been proven as an effective alternative to 1080 for aerial control 
of rodents, but it is not recommended for repeated aerial control of rodents. 
One-off use for eradication can result in benefits that significantly outweigh non-
target effects (Eason et al. 2001, 2002) and this use pattern is recommended. 
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 4. New non-anticoagulant candidate 
compounds
In this section, we examine the potential of a new candidate vertebrate pesticide, 
para-aminopriophenone (PAPP), for aerial control of rodents. This is currently 
being developed for the control of stoats and cats in New Zealand. 
 4 . 1  P A R A - A M I N O P R O P I O P H E N O N E  ( P A P P )  A N D 
R E L A T E D  C O M P O U N D S
  General information and history of use
Para-aminopropiophenone, or PAPP, was originally studied as a protection from 
the effects of radiation and then for the treatment of cyanide poisoning. It is toxic 
to carnivores, with birds and humans being less sensitive (Fisher & O’Connor 
2007; Murphy et al. 2007). The toxin is being developed for the humane control 
of stoats and feral cats in New Zealand, and foxes (Vulpes vulpes), feral cats 
and wild dogs in Australia. The effectiveness of PAPP or related compounds as 
rodenticides is a current field of research (Eason et al. 2009). 
  Mode of action
The toxic effects of PAPP are related to its ability to reduce the oxygen 
carrying capacity of the red blood cells, resulting in haemoglobin rapidly being 
converted into methaemoglobin. This sharply reduces the oxygen carrying 
capacity of the blood, which leads rapidly to unconsciousness and death due to 
respiratory failure; for example, cats and foxes are usually unconscious within 
30–45 minutes. Methaeglobinaemia inducing agents like PAPP are humane, as 
they induce lethargy and death follows rapidly (Murphy et al. 2007). Methylene 
blue, which is available from veterinarians, will reverse the effects of PAPP and 
thus can be administered as an antidote (Murphy et al. 2007). 
  Toxicity
Cats and stoats are generally more susceptible to PAPP than most other species 
(Table 13). However, related compounds that are more toxic to rodents are 
being explored (Eason et al. 2009).
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SPECIES LD50 mg/kg 
Cat (Felis catus) 5.6
Fox (Vulpes vulpes) 14.1
Stoat (Mustela erminea) 9.3
Ferret (Mustela putorius) 29
Possum (Trichosurus vulpecula) > 500
Wallaby (Wallabia rufogrisea frutica) 89
Mouse (Mus musculus) 223
Rat (Rattus rattus) 221
TABLE 13.    ACUTE ORAL TOxICITy (LD50 mg/kg)  FOR  
PARA-AMINOPROPIOPHENONE (PAPP). 
Prepared from information in Savarie et al. (1983) and O’Connor (2002).
  Summary of key features
Advantages: Disadvantages:
•	 Simple	antidote		 •	 Not	yet	registered	for	use	in
•	 Humane	(very	rapid	action)	 	 New	Zealand—pending	2009
•	 Low	secondary-poisoning	risk	 •	 Effectiveness	in	baits	for	rodents
   unknown
	 	 •	 Some	toxicity	to	birds
  Recommendations
PAPP or related compounds could be considered as an option for aerial control 
of rodents as well as cats and stoats if current research shows they have effective 
rodenticidal properties in mice and rats. Bait specifications similar to those for 
aerial 1080 would need to be developed to limit non-target impacts.
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 5. Discussion
Brodifacoum is the most potent alternative to 1080 currently available. The LD50 
for rats is 0.27 mg/kg and for mice is 0.4 mg/kg, and it has been used aerially to 
eradicate rats from several islands off the coast of New Zealand (Taylor 1984; 
Taylor & Thomas 1989, 1993; Towns 1991). However, brodifacoum is also 
extremely toxic to a number of other species, which, coupled with its tendency 
to bioaccumulate, makes it unsuitable for routine aerial broadcast on mainland 
New Zealand. 
From the first-generation anticoagulant class of compounds, diphacinone 
represents the best alternative option to 1080 for the aerial control of rodents at 
present, as it is more potent than pindone or warfarin, and equipotent but less 
persistent than coumatetralyl (Fisher et al. 2003). This is supported by the recent 
registration of diphacinone by the US EPA for aerial broadcast for conservation 
purposes (US EPA 2008). Another alternative to 1080 worthy of consideration is 
cholecalciferol, particularly at the 0.4% loading concentration, as this compound 
lacks toxicity to birds and will not bioaccummulate (Eason et al. 2000). 
Zinc phosphide, and a cholecalciferol and coumatetralyl combination are options 
to consider further when they have been registered and have an established 
safety record in New Zealand (Eason et al. 2008). Norbormide would not be as 
suitable, as it is too species-specific, is not effective on mice, and is no longer 
registered anywhere in world. Bromethalin has few advantages over other options 
except that it is already registered in the USA, although not for field use; at least 
$500,000 would be needed to research and develop this compound for field use 
in New Zealand. 
New toxins that act on different physiological processes could usefully prevent the 
development of bait shyness, aversion or resistance. Para-aminopropiophenone 
(PAPP) is being developed for stoat and feral cat control in New Zealand, and the 
rodenticidal potential of this class of compounds will be determined in 2009/10. 
If a suitable new rodenticide is identified from this new class of red blood cell 
toxicants, then aerial bait containing a new toxin with a different and humane 
mode of action from conventional rodenticides may become an option in the 
future. 
As an alternative option, at some stage in the future toxins extracted directly 
from New Zealand plants may be more acceptable to the New Zealand public 
than some of the synthetic toxins we use at present. For some plant species 
(e.g. tutu Coriaria arborea, karaka Corynocarpus laevigatus and kowhai 
Sophora microphylla), the toxicity to rodents (including LD50 information), 
toxin extraction methods and the chemistry of the toxicant have already been 
described. Researchers at Lincoln University are currently exploring the potential 
of natural New Zealand toxins. 
The Department of Conservation, FRST, AHB and others are already undertaking 
research to advance the use of alternatives to 1080 for the control of rodents 
and possums, and it will be important to extend this research to develop the 
necessary information to support their use and registration for aerial control of 
rodents.
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In the short to medium term, the focus should be on those compounds that 
are already registered in New Zealand or other countries. Thus, the preferred 
alternatives to 1080 are, in order: 
Brodifacoum for island eradication or exceptional ‘one-off’ use on the 1. 
mainland
Diphacinone 2. 
Cholecalciferol 3. 
C+C 4. 
Zinc phosphide 5. 
A key advantage of diphacinone and cholecalciferol is that they are already 
registered for field use and could be registered for aerial application in the short 
to medium term. However, C+C and zinc phosphide are also well advanced 
towards registration. 
In the longer term, the preferred alternative to 1080 would be a novel, humane 
red blood cell toxin, if it can be successfully developed.
Availability and registration status could influence this priority list in the future. 
Research and development needs to be consolidated if any of these new options 
are to become available for aerial control of rodents. 
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